Screening for hydroxylation and acetylation polymorphisms in man via simultaneous analysis of urinary metabolites of mephenytoin, dextromethorphan and caffeine by capillary electrophoretic procedures
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 656 (1) , 219-231
- https://doi.org/10.1016/0378-4347(94)00059-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prediction of phenotype for acetylation and for debrisoquine hydroxylation by DNA-tests in healthy human volunteersEuropean Journal of Clinical Pharmacology, 1992
- Rapid screening for polymorphisms in dextromethorphan and mephenytoin metabolism.British Journal of Clinical Pharmacology, 1990
- Genetic Polymorphisms of Drug MetabolismPublished by Elsevier ,1990
- GC and GC-MS procedures for simultaneous phenotyping with dextromethorphan and mephenytoinClinica Chimica Acta; International Journal of Clinical Chemistry, 1988
- Pharmacogenetics of dextromethorphan O-demethylation in manXenobiotica, 1986
- Polymorphic dextromethorphan metabolism: Co-segregation of oxidative O-demethylation with debrisoquin hydroxylationClinical Pharmacology & Therapeutics, 1985
- Genetically Determined Variability in Acetylation and Oxidation Therapeutic ImplicationsDrugs, 1985
- A simple test for acetylator phenotype using caffeine.British Journal of Clinical Pharmacology, 1984
- Pharmacogenetics of mephenytoin: A new drug hydroxylation polymorphism in manEuropean Journal of Clinical Pharmacology, 1984
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982